Identify factors behind balance confidence

Trial ID
NCT06751797
Official Title
Balance Confidence, Kinesiophobia, and Associated Factors in Parkinson's Disease: A Controlled Study
Goal
Identify factors behind balance confidence
Status
RECRUITING
Sponsor
Beylikduzu State Hospital
Study Type
OBSERVATIONAL
Enrollment
62 participants
Conditions
Parkinson Disease
Interventions
No intervention

Plain-Language Summary

The goal is to understand how confident people with Parkinson's feel about their balance, how much fear of movement (kinesiophobia) they have, and which clinical or physical factors are linked to those feelings. Participants will not receive any new treatment, instead they will complete assessments and questionnaires and undergo observational tests that measure balance confidence, kinesiophobia, and related clinical features so researchers can spot patterns that may guide rehab or fall-prevention approaches. The study is enrolling volunteers aged 50 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3, who have an MMSE of 24 or higher and no other neurological, musculoskeletal, psychiatric conditions, or interfering medications.

Locations

  • Beylikdüzü State Hospital, Istanbul, Beylikdüzü, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying No intervention. The goal is to understand how confident people with Parkinson's feel about their balance, how much fear of movement (kinesiophobia) they have, and which clinical or physical factors are linked to those feelings. Participants will not receive any new treatment, instead they will complete assessments and questionnaires and undergo observational tests that measure balance confidence, kinesiophobia, and related clinical features so researchers can spot patterns that may guide rehab or fall-prevention approaches. The study is enrolling volunteers aged 50 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3, who have an MMSE of 24 or higher and no other neurological, musculoskeletal, psychiatric conditions, or interfering medications.
Who can participate?
Participants must be between 50 Years and 80 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 1 month.

View on ClinicalTrials.gov